PGF2α was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). The ELISA kits for mouse IL-6 and mouse VEGF were purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Phospho-specific p44/p42 MAP kinase antibodies, p44/p42 MAP kinase antibodies, phospho-specific p38 MAP kinase antibodies, and p38 MAP kinase antibodies were obtained from Cell Signaling Technology, Inc. (Danvers, MA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). An ECL Western blotting detection system was obtained from GE Healthcare Life Sciences (Buckinghamshire, UK). Negative control-small interfering RNA (siRNA) (Silencer Negative Control #1 siRNA (Neg)) and HSP22-siRNA (s206904 (#1) and s96094 (#2)) were purchased from Ambion (Austin, TX, USA). Other materials and chemicals were obtained from commercial sources.
Hsp22 sirna s206904 1 and s96094 2
Manufactured by Thermo Fisher Scientific
Sourced in United States
HSP22-siRNA (s206904 (#1) and s96094 (#2)) are two different siRNA (small interfering RNA) sequences targeting the HSP22 (Heat Shock Protein 22) gene. siRNAs are used to silence or knockdown the expression of specific genes in cells. No further details on the intended use or application of these particular siRNA products are provided.
Automatically generated - may contain errors
Lab products found in correlation
Glyceraldehyde 3 phosphate dehydrogenase gapdh antibody, by Santa Cruz Biotechnology (3 mentions)
P44 p42 map kinase antibodies, by Cell Signaling Technology (3 mentions)
P38 map kinase antibodies, by Cell Signaling Technology (3 mentions)
Elisa kits for mouse il 6 and mouse vegf, by R&D Systems (3 mentions)
Ecl western blotting detection system, by GE Healthcare (3 mentions)
Phospho specific p44 p42 map kinase antibodies, by Cell Signaling Technology (2 mentions)
Phospho specific p38 map kinase antibodies, by Cell Signaling Technology (2 mentions)
Pgf2α, by Merck Group (1 mentions)
Pgf2a, by Merck Group (1 mentions)
3 protocols using hsp22 sirna s206904 1 and s96094 2
1
PGF2α Signaling Pathway Regulation
2
Investigating Heat Shock Protein 22 Function
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
PGF2a was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). The ELISA kits for mouse IL-6 and mouse VEGF were purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Phospho-specific p44/p42 MAP kinase antibodies, p44/p42 MAP kinase antibodies, phospho-specific p38 MAP kinase antibodies and p38 MAP kinase antibodies were obtained from Cell Signaling Technology, Inc. (Danvers, MA, USA). Glyceraldehyde-3phosphate dehydrogenase (GAPDH) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). An ECL Western blotting detection system was obtained from GE Healthcare Life Sciences (Buckinghamshire, UK). Negative control-small interfering RNA (siRNA) (Silencer Negative Control #1 siRNA (Neg)) and HSP22-siRNA (s206904 (#1) and s96094 (#2)) were purchased from Ambion (Austin, TX, USA).
Other materials and chemicals were obtained from commercial sources.
Other materials and chemicals were obtained from commercial sources.
3
PGF2-Induced MAPK Signaling Pathway
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
PGF2 was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). The ELISA kits for mouse IL-6 and mouse VEGF were purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Phospho-speci c p44/p42 MAP kinase antibodies, p44/p42 MAP kinase antibodies, phospho-speci c p38 MAP kinase antibodies and p38 MAP kinase antibodies were obtained from Cell Signaling Technology, Inc. (Danvers, MA, USA).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). An ECL Western blotting detection system was obtained from GE Healthcare Life Sciences (Buckinghamshire, UK). Negative control-small interfering RNA (siRNA) (Silencer Negative Control #1 siRNA (Neg)) and HSP22-siRNA (s206904 (#1) and s96094 (#2)) were purchased from Ambion (Austin, TX, USA). Other materials and chemicals were obtained from commercial sources.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). An ECL Western blotting detection system was obtained from GE Healthcare Life Sciences (Buckinghamshire, UK). Negative control-small interfering RNA (siRNA) (Silencer Negative Control #1 siRNA (Neg)) and HSP22-siRNA (s206904 (#1) and s96094 (#2)) were purchased from Ambion (Austin, TX, USA). Other materials and chemicals were obtained from commercial sources.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!